| Filed On | Filing |
|---|---|
| 07 Jun 2016 |
Form 4: Goff Brian, EVP and President, Hematology
Received 2,881 shares as a grant or award · Returned 70,047 shares to the issuer · Disposed of 482,708 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Hombach Robert J., EVP. CFO and COO
Received 16,356 shares as a grant or award · Returned 209,089 shares to the issuer · Disposed of 1,040,210 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Glasspool John, See Remarks
Received 1,461 shares as a grant or award · Returned 41,099 shares to the issuer · Disposed of 118,754 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Leonardi Jacopo, EVP and President, Immunology
Received 1,033 shares as a grant or award · Returned 57,459 shares to the issuer · Disposed of 335,318 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Stroucken Albert P L, Director
Returned 22,890 shares to the issuer · Disposed of 38,900 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Rosa-bjorkeson Dagmar, EVP and President, Biosimilars
Returned 71,293 shares to the issuer · Disposed of 141,222 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Edwards Peter G, SVP and General Counsel
Returned 216,343 shares to the issuer · Disposed of 76,202 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Fosler Gail D, Director
Returned 39,364 shares to the issuer · Disposed of 37,971 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Orloff John J, See Remarks
Returned 96,384 shares to the issuer · Disposed of 191,898 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Forsyth John D, Director
Returned 27,827 shares to the issuer · Disposed of 38,900 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Meek David D., EVP and President, Oncology
Returned 51,640 shares to the issuer · Disposed of 295,463 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Hantson Ludwig, Director
Received 16,356 shares as a grant or award · Returned 435,102 shares to the issuer · Disposed of 1,518,667 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Hockmeyer Wayne T, Director
Returned 19,039 shares to the issuer · Disposed of 46,191 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Law Anne-marie, EVP & Head of Human Resources
Returned 85,262 shares to the issuer · Disposed of 176,428 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Zagame Patrice, See Remarks
Returned 88,942 shares to the issuer · Disposed of 196,504 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Gavin James R Iii, Director
Returned 30,747 shares to the issuer · Disposed of 38,900 Stock Option (Right to Buy) (Disposition to Issuer) · Disposed of 4,499 Deferred Compensation Plan Baxalta Common Stock Fund (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Nader Francois, Director
Returned 7,657 shares to the issuer · Disposed of 5,960 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Mccoy John A., SVP and Controller
Received 854 shares as a grant or award · Returned 24,909 shares to the issuer · Disposed of 119,508 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Ferrante Karen Jean, Director
Returned 7,657 shares to the issuer · Disposed of 5,960 Stock Option (Right to Buy) (Disposition to Issuer) |
| 07 Jun 2016 |
Form 4: Devitt Blake E, Director
Returned 32,857 shares to the issuer · Disposed of 47,971 Stock Option (Right to Buy) (Disposition to Issuer) |
Loading...
